Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Cantor Fitzgerald
Citi
Julphar
Cipla
Daiichi Sankyo
Medtronic
Mallinckrodt
Fish and Richardson
Chubb

Generated: January 19, 2018

DrugPatentWatch Database Preview

Bausch And Lomb Company Profile

« Back to Dashboard

Summary for Bausch And Lomb
International Patents:146
US Patents:22
Tradenames:64
Ingredients:53
NDAs:75

Drugs and US Patents for Bausch And Lomb

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb BESIVANCE besifloxacin hydrochloride SUSPENSION/DROPS;OPHTHALMIC 022308-001 May 28, 2009 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Bausch And Lomb TROPICAMIDE tropicamide SOLUTION/DROPS;OPHTHALMIC 040067-001 Jul 27, 1994 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bausch And Lomb DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 090037-001 Jul 14, 2009 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bausch And Lomb OPCON-A naphazoline hydrochloride; pheniramine maleate SOLUTION/DROPS;OPHTHALMIC 020065-001 Jun 8, 1994 OTC Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bausch And Lomb ISTALOL timolol maleate SOLUTION/DROPS;OPHTHALMIC 021516-001 Jun 4, 2004 AT2 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Bausch And Lomb PROLENSA bromfenac sodium SOLUTION/DROPS;OPHTHALMIC 203168-001 Apr 5, 2013 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Bausch And Lomb NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE bacitracin zinc; hydrocortisone; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 064068-001 Oct 30, 1995 AT RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bausch And Lomb RETISERT fluocinolone acetonide IMPLANT;INTRAVITREAL 021737-001 Apr 8, 2005 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Bausch And Lomb DESMOPRESSIN ACETATE desmopressin acetate SPRAY, METERED;NASAL 074830-001 Jan 25, 1999 AB RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bausch And Lomb Inc XIBROM bromfenac sodium SOLUTION/DROPS;OPHTHALMIC 021664-001 Mar 24, 2005 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Bausch And Lomb

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch And Lomb BESIVANCE besifloxacin hydrochloride SUSPENSION/DROPS;OPHTHALMIC 022308-001 May 28, 2009 ➤ Subscribe ➤ Subscribe
Bausch And Lomb LOTEMAX loteprednol etabonate SUSPENSION/DROPS;OPHTHALMIC 020583-001 Mar 9, 1998 ➤ Subscribe ➤ Subscribe
Bausch And Lomb VITRASERT ganciclovir IMPLANT;IMPLANTATION 020569-001 Mar 4, 1996 ➤ Subscribe ➤ Subscribe
Bausch And Lomb ZYLET loteprednol etabonate; tobramycin SUSPENSION/DROPS;OPHTHALMIC 050804-001 Dec 14, 2004 ➤ Subscribe ➤ Subscribe
Bausch And Lomb ZYLET loteprednol etabonate; tobramycin SUSPENSION/DROPS;OPHTHALMIC 050804-001 Dec 14, 2004 ➤ Subscribe ➤ Subscribe
Bausch And Lomb LOTEMAX loteprednol etabonate SUSPENSION/DROPS;OPHTHALMIC 020583-001 Mar 9, 1998 ➤ Subscribe ➤ Subscribe
Bausch And Lomb LOTEMAX loteprednol etabonate SUSPENSION/DROPS;OPHTHALMIC 020583-001 Mar 9, 1998 ➤ Subscribe ➤ Subscribe
Bausch And Lomb ZYLET loteprednol etabonate; tobramycin SUSPENSION/DROPS;OPHTHALMIC 050804-001 Dec 14, 2004 ➤ Subscribe ➤ Subscribe
Bausch And Lomb ALREX loteprednol etabonate SUSPENSION/DROPS;OPHTHALMIC 020803-001 Mar 9, 1998 ➤ Subscribe ➤ Subscribe
Bausch And Lomb ALREX loteprednol etabonate SUSPENSION/DROPS;OPHTHALMIC 020803-001 Mar 9, 1998 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for BAUSCH AND LOMB drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Ophthalmic Solution 1.5% ➤ Subscribe 9/9/2013
➤ Subscribe Ophthalmic Solution 0.07% ➤ Subscribe 7/26/2013
➤ Subscribe Ophthalmic Solution 0.5% ➤ Subscribe 10/19/2012

Non-Orange Book US Patents for Bausch And Lomb

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,056,893 Topical treatment for prevention of ocular infections ➤ Subscribe
8,252,307 Method for treating and/or preventing retinal diseases with sustained release corticosteroids ➤ Subscribe
8,497,304 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid ➤ Subscribe
7,282,589 Acid addition salt of optically active piperidine compound and process for preparing the same ➤ Subscribe
6,307,052 Acid-addition salts of optically active piperidine compound and process for producing the same ➤ Subscribe
7,732,415 Topical treatment or prevention of ocular infections ➤ Subscribe
6,569,443 Topical treatment or prevention of ocular infections ➤ Subscribe
6,239,113 Topical treatment or prevention of ocular infections ➤ Subscribe
7,749,970 Topical treatment of prevention of ocular infections ➤ Subscribe
8,883,825 Aqueous liquid preparations and light-stabilized aqueous liquid preparations ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Bausch And Lomb Drugs

Supplementary Protection Certificates for Bausch And Lomb Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB02/027 United Kingdom ➤ Subscribe PRODUCT NAME: 2-(2-AMINO-1,6-DIHYDRO-6-OXO-PURIN-9-YL)-METHOXY-3-HYDROXY-1-PROPANYL-L-VALINATE HYDROCHLORIDE (VALGANCICLOVIR HYDROCHLORIDE); REGISTERED: NL RVG 25992 20010920; UK PL 00031/0599 20020425
0722 Netherlands ➤ Subscribe PRODUCT NAME: TOBRAMYCINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: C(2011)5394 20110720
C0012 France ➤ Subscribe PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808
138 Luxembourg ➤ Subscribe PRODUCT NAME: RITUXIMAB ET HYALURONIDASE HUMAINE RECOMBINANTE; FIRST REGISTRATION DATE: 20140326
/1997 Austria ➤ Subscribe PRODUCT NAME: LATANOPROST UND SEINE THERAPEUTISCH AKTIVEN UND PHYSIOLOGISCH ANNEHMBAREN DERIVATE; NAT. REGISTRATION NO/DATE: 1-22019 19970627; FIRST REGISTRATION: SE 12716 19960718
C/GB97/085 United Kingdom ➤ Subscribe PRODUCT NAME: LEVOFLOXACIN, OPTIONALLY IN THE FORM OF A HEMIHYDRATE; REGISTERED: UK 13402/0011 19970606; UK 13402/0012 19970606; UK 13402/0013 19970606
2015000061 Germany ➤ Subscribe PRODUCT NAME: TRASTUZUMAB UND RECOMBINANTE HUMANE HYALURONIDASE; REGISTRATION NO/DATE: EU/1/00/145/002 20130826
00683 Netherlands ➤ Subscribe PRODUCT NAME: BRIMONIDINE EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN VOOR TOEPASSING ALS GENEESMIDDEL VOOR DE BEHANDELING VAN DOOR ROSACEA GEINDUCEERDE ROODHEID; REGISTRATION NO/DATE: EU/1/13/904 20140225
C0041 Belgium ➤ Subscribe PRODUCT NAME: LEVOFLOXACINUM HEMIHYDRICUM; NAT. REGISTRATION NO/DATE: 354 IS 370 F3 19980624; FIRST REGISTRATION: GB 134020011 19970606
780 Luxembourg ➤ Subscribe PRODUCT NAME: TRASTUZUMAB ET HYALURONIDASE HUMAINE RECOMBINANTE; FIRST REGISTRATION DATE: 20130826
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Covington
Accenture
Cerilliant
Harvard Business School
Cipla
Farmers Insurance
Julphar
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot